文献速递胸部肿瘤放疗放疗物理与技术

融合分次间偏差与生物效应的超分割放疗TCP和NTCP建模新框架

A Novel TCP and NTCP Modeling Framework Incorporating Inter-Fractional Deviations and Biological Effectiveness for Hyper-fractionated Radiotherapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-10-13

本研究针对局限期小细胞肺癌(LS-SCLC)超分割放疗,构建了基于锥形束CT(CBCT)分次间解剖和生物有效剂量(BED)的TCP与NTCP模型。与计划CT剂量相比,CBCT累积剂量模型对正常组织毒性的判别更优,对局部无进展生存的建模略有改善。

要点

  • CBCT累积剂量NTCP模型对≥2级放射性肺炎的AUC高于计划CT模型(0.67 vs. 0.59)。
  • CBCT累积剂量NTCP模型对≥3级放射性食管炎的AUC为0.62,优于计划CT的0.58。
  • CBCT剂量TCP模型对LPFS的AUC略高于计划CT(GTV 45 Gy:0.80 vs. 0.79)。

核心结论

  • 融合分次间偏差和生物有效剂量的TCP与NTCP模型提高了LS-SCLC超分割放疗的预测准确性,为治疗计划和毒性管理提供初步证据。

研究设计与样本

  • 基于CBCT与计划CT形变配准累积分次间剂量,在BED框架下构建TCP和NTCP模型。
  • TCP采用LQRG模型,NTCP采用LKB模型,比较计划剂量与CBCT累积剂量的模型性能。
  • 以ROC曲线AUC、负对数似然(NLL)和AIC评估模型对LPFS、放射性肺炎和放射性食管炎的预测表现。

主要发现

  • CBCT剂量对正常组织毒性的判别优于计划CT剂量。
  • ≥2级放射性肺炎:CBCT模型AUC 0.67 vs. 计划CT 0.59,NLL 62.39 vs. 66.13。
  • ≥3级放射性食管炎:CBCT模型AUC 0.62 vs. 计划CT 0.58,NLL 55.55 vs. 56.64。
  • 以观察到的LPFS为参考,CBCT剂量TCP建模较计划CT略有改善:GTV 45 Gy的AUC 0.80 vs. 0.79,GTV 54 Gy的AUC 0.77 vs. 0.75。

临床怎么用

  • 对于接受超分割放疗的LS-SCLC患者,可考虑基于CBCT累积剂量和BED进行TCP/NTCP建模以辅助治疗计划和毒性管理。

局限性

  • 研究结论为初步证据,尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: High-dose hyper-fractionated radiotherapy has been recently included in NCCN guidelines for limited-stage small cell lung cancer (LS-SCLC), which clinical outcomes are dependent on actually delivered biologically effective dose (BED). However, most tumor control probability (TCP) and normal tissue complication probability (NTCP) models rely on planed physical dose without considering inter-fractional deviations and BED of fractionization. This study aims to develop TCP and NTCP models for LS-SCLC incorporating CBCT-based inter-fractional anatomies and hyper-fractional radiobiological dose. METHODS AND MATERIALS: Inter-fractional dose was accumulated based on deformable image registration between CBCT and planning CT (pCT). Both TCP and NTCP were formulated within a BED-based framework, using dose-volume parameters calculated from planned dose and CBCT-based accumulated dose for comparison. The LQ model with "4R" effects and Gompertzian tumor growth (LQRG) and Lyman-Kutcher-Burman (LKB) models were used for TCP and NTCP modeling. Based on the receiver operating characteristic (ROC) curve (AUC), negative log-likelihood (NLL), and Akaike information criterion (AIC), model performances were assessed for local progression-free survival (LPFS), radiation pneumonitis and radiation esophagitis. RESULTS: Compared with pCT dose, CBCT dose showed superior discrimination of normal tissue toxicity. For grade ≥2 radiation pneumonitis, the CBCT-based NTCP model achieved significantly higher AUC (0.67 vs. 0.59) and lower NLL (62.39 vs. 66.13) than that of the pCT-based mode. Superiority of CBCT-based NTCP model was also observed for grade ≥3 radiation esophagitis, i.e., AUC (0.62 vs. 0.58) and NLL (55.55 vs. 56.64). Using the observed LPFS as reference, marginally improved TCP modeling was observed using CBCT dose than that of pCT, where the AUC values were 0.80 vs. 0.79 (GTV 45 Gy) and 0.77 vs. 0.75 (GTV 54 Gy). CONCLUSIONS: By incorporating inter-fractional deviation and biological effectiveness, the improved accuracy of TCP and NTCP models provides preliminary evidence supporting the treatment planning and toxicity management for LS-SCLC patients treated with the hyper-fractionated radiotherapy, which needs further clinical validation.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Kong X, Fu X, Yu J, et al. A Novel TCP and NTCP Modeling Framework Incorporating Inter-Fractional Deviations and Biological Effectiveness for Hyper-fractionated Radiotherapy. Int J Radiat Oncol Biol Phys. 2026. PMID: 42869300. doi:10.1016/j.ijrobp.2026.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。